Relugolix

Myovant and Pfizer's uterine fibroids med scores FDA nod, setting up showdown with AbbVie
Fierce Pharma
Wed, 05/26/21 - 11:58 pm
Myovant Sciences
Pfizer
FDA
Relugolix
uterine fibroids
Pfizer/Myovant take relugolix contraceptive combination pill into phase 3
Pharmaforum
Wed, 04/14/21 - 09:32 am
Pfizer
Myovant
Relugolix
contraceptives
clinical trials
Myovant/Pfizer's Relugolix Combo Therapy Shows Sustained Clinical Benefit In Uterine Fibroids
Benzinga
Wed, 03/24/21 - 10:16 am
Myovant
Pfizer
clinical trials
Relugolix
uterine fibroids
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Tue, 03/9/21 - 10:45 am
Clarivate
Biogen
Eisai
aducanumab
UCB Pharma
bimekizumab
Relugolix
Pfizer
Takeda
Myovant
vericiguat
Bayer
Merck
Myovant Up on $4.2B Pfizer Pact to Develop Prostate-Cancer Drug
TheStreet.com
Mon, 12/28/20 - 10:42 am
Myovant
Pfizer
prostate cancer
Orgovyx
Relugolix
In groundbreaking move, FDA approves Myovant's relugolix as the first once-a-day pill for advanced prostate cancer
Endpoints
Sat, 12/19/20 - 11:24 pm
Myovant Sciences
Relugolix
FDA
prostate cancer
Orgovyx
Myovant shows disappointing prostate cancer data on the way to the FDA, stock sinks
Endpoints
Tue, 09/29/20 - 12:13 pm
Myovant
Relugolix
prostate cancer
AbbVie
Lupron
clinical trials
Looking at a groundbreaking advance, Myovant gets a priority review at FDA
Endpoints
Mon, 06/22/20 - 11:10 am
Myovant
FDA
priority review
Relugolix
prostate cancer
ASCO: Myovant details speedy effects of prostate cancer med relugolix
Fierce Biotech
Mon, 06/1/20 - 10:45 am
Myovant
ASCO 2020
Relugolix
prostate cancer
clinical trials
Myovant Squares Off with AbbVie On Endometriosis Treatment
Motley Fool
Sun, 04/26/20 - 01:49 pm
Myovant Sciences
AbbVie
endometriosis
Relugolix
Orilissa
clinical trials
Myovant's Uterine Fibroid Drug Relugolix Produces Positive Data in a Long-Term Study
Motley Fool
Mon, 02/10/20 - 11:27 pm
Myovant Sciences
Relugolix
uterine fibroids
clinical trials
Upcoming events – Pfizer's abrocitinib and Myovant's relugolix
EP Vantage
Sat, 01/11/20 - 12:01 am
Pfizer
abrocitinib
Dupixent
Sanofi
Myovant
Relugolix
uterine fibroids
Is Myovant's New Prostate Cancer Drug a Game Changer?
Motley Fool
Tue, 11/26/19 - 10:33 am
Myovant Sciences
prostate cancer
clinical trials
Relugolix
Myovant to submit lead drug for prostate cancer approval after Phase 3 results
Biopharma Dive
Tue, 11/19/19 - 10:12 am
Myovant Sciences
prostate cancer
clinical trials
Relugolix
Myovant's uterine fibroid drug looks competitive in PhIII — but can they vanquish mighty AbbVie?
Endpoints
Tue, 07/23/19 - 10:05 am
Myovant
uterine fibroids
Relugolix
AbbVie
Elagolix
Myovant hits goal in uterine fibroid phase 3, teeing up AbbVie showdown
Fierce Biotech
Tue, 05/14/19 - 09:26 am
Myovant Sciences
Relugolix
clinical trials
uterine fibroids
AbbVie
Elagolix
This drug may be able to treat both women’s health disorders and prostate cancer
Marketwatch
Thu, 10/12/17 - 09:31 am
Myovant
Relugolix
prostate cancer
uterine fibroids
endometriosis